Company profile: Vistin Pharma
1.1 - Company Overview
Company description
- Provider of active pharmaceuticals and solid dosage forms focused on metformin, manufacturing and supplying metformin in various forms, including Metformin Hydrochloride (API) meeting purity and flow quality standards and Metformin Direct Compressible Premix for immediate-release tablet compression.
Products and services
- Metformin Direct Compressible Premix (Metformin DC): Vistin Pharma offers a direct-compressible premix of metformin hydrochloride with magnesium stearate, engineered for direct compression into immediate-release tablets from the premixed blend
- Metformin Direct-Release Tablets: The company supplies solid-dosage direct-release metformin tablets, developed in line with their variety of forms to meet client needs
- Metformin Hydrochloride (API): Vistin Pharma produces the hydrochloride salt API for metformin-based diabetes medicines, synthesized and processed to meet purity and flow quality standards.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vistin Pharma
CenExel
HQ: United States
Website
- Description: Provider of clinical research site network services supporting phase I-IV clinical trials, offering medical and scientific services to assist in the design and execution of clinical studies. Operates multiple centers across the country, delivering comprehensive resources to enhance research outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CenExel company profile →
Emmes
HQ: United States
Website
- Description: Provider of clinical research services as a contract research organization for public health and biopharmaceutical innovation, collaborating with leading researchers to tackle global public health challenges.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emmes company profile →
3P Biopharmaceuticals
HQ: Spain
Website
- Description: Provider of biologics and cell therapy development and manufacturing services. Offers comprehensive CDMO support, including process and analytical development, preclinical and clinical supply, and commercial production. Produces proteins via mammalian (CHO, NS0, BHK-21, HEK293, Hybridoma) and microbial (E. coli, P. pastoris, S. cerevisiae, H. pylori, S. noursei) systems, and provides cell therapy technology transfer, process development, cell culture, and GMP certification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 3P Biopharmaceuticals company profile →
VintaBio
HQ: United States
Website
- Description: Provider of cell and gene therapy manufacturing services to pharmaceutical and biotechnology organizations to alleviate the viral vector bottleneck. Offerings include GMP manufacturing with integrated supply chain, process development and toxicology materials from cell line to drug product, research vector production, analytical assays for quality control and release, and CMC support for IND and pre-BLA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VintaBio company profile →
Alpex
HQ: Switzerland
Website
- Description: Provider of research and development and production of orally dispersible tablets (ODT), also known as fast melt, and effervescent tablets. Offers a unique proprietary covering ODT technology, supported by high production capacity and advanced R&D technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alpex company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vistin Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vistin Pharma
2.2 - Growth funds investing in similar companies to Vistin Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vistin Pharma
4.2 - Public trading comparable groups for Vistin Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →